Envafolimab Combined With Endostatin in Recurrent or Metastatic MSS-type Colorectal Cancer

NCT05551247 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Neoplasms

Interventions

DRUG: Envafolimab
DRUG: recombinant human endostatin (endostatin)

Sponsor

First Affiliated Hospital Xi'an Jiaotong University